Unknown

Dataset Information

0

Pediatric cardiomyopathy: importance of genetic and metabolic evaluation.


ABSTRACT:

Background

Cardiomyopathy is a heterogeneous disease with a strong genetic component. A research-based pediatric cardiomyopathy registry identified familial, syndromic, or metabolic causes in 30% of children. However, these results predated clinical genetic testing.

Methods and results

We determined the prevalence of familial, syndromic, or metabolic causes in 83 consecutive unrelated patients referred for genetic evaluation of cardiomyopathy from 2006 to 2009. Seventy-six percent of probands (n = 63) were categorized as familial, syndromic, or metabolic. Forty-three percent (n = 18) of hypertrophic cardiomyopathy (HCM) patients had mutations in sarcomeric genes, with MYH7 and MYBPC3 mutations predominating. Syndromic (17%; n = 7) and metabolic (26%; n = 11) causes were frequently identified in HCM patients. The metabolic subgroup was differentiated by decreased endocardial shortening fraction on echocardiography. Dilated cardiomyopathy (DCM) patients had similar rates of syndromic (20%; n = 5) and metabolic (16%; n = 4) causes, but fewer familial cases (24%; n = 6) compared with HCM patients.

Conclusions

The cause of cardiomyopathy is identifiable in a majority of affected children. An underlying metabolic or syndromic cause is identified in >35% of children with HCM or DCM. Identification of etiology is important for management, family-based risk assessment, and screening.

SUBMITTER: Kindel SJ 

PROVIDER: S-EPMC3345128 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pediatric cardiomyopathy: importance of genetic and metabolic evaluation.

Kindel Steven J SJ   Miller Erin M EM   Gupta Resmi R   Cripe Linda H LH   Hinton Robert B RB   Spicer Robert L RL   Towbin Jeffrey A JA   Ware Stephanie M SM  

Journal of cardiac failure 20120310 5


<h4>Background</h4>Cardiomyopathy is a heterogeneous disease with a strong genetic component. A research-based pediatric cardiomyopathy registry identified familial, syndromic, or metabolic causes in 30% of children. However, these results predated clinical genetic testing.<h4>Methods and results</h4>We determined the prevalence of familial, syndromic, or metabolic causes in 83 consecutive unrelated patients referred for genetic evaluation of cardiomyopathy from 2006 to 2009. Seventy-six percent  ...[more]

Similar Datasets

| S-EPMC4244613 | biostudies-literature
| S-EPMC8874151 | biostudies-literature
| S-EPMC8256333 | biostudies-literature
| S-EPMC8200745 | biostudies-literature
| S-EPMC10984286 | biostudies-literature
| S-EPMC8188401 | biostudies-literature
| S-EPMC6906246 | biostudies-literature
| S-EPMC6863618 | biostudies-literature
| S-EPMC8554517 | biostudies-literature
| S-EPMC4128369 | biostudies-other